Published Date: November 2025
Computational Biology is a biologically focused interdisciplinary area that uses computer science, mathematics, and statistics to analyse biological systems such as genes, proteins, cells, and even whole organisms. The need for precision medicine, rapid advances in genomics and proteomics, and greater use of AI and machine learning in biological data processing are all important factors driving the computational biology market's growth.
Furthermore, the significant increase in drug discovery and development activities, the desire for low-cost research solutions, and the spread of cloud-based computational platforms are all factors contributing to market growth. The rise in chronic diseases, as well as global attention to biotechnology and healthcare advances, are important factors driving the market's expansion.
Segmentation Analysis:
|
By Component |
Hardware (High-Performance Computing (HPC) Systems, Cloud Computing Infrastructure, and Others), Software (Simulation & Modeling Software, Sequence Analysis Software, and Others), and Services (Contract Research Services, Consulting & Implementation, and Others) |
|
By Tools |
Databases, Algorithms, Simulation Tools, and Others |
|
By Deployment Mode |
Cloud-based, On-premises, and Hybrid |
|
By Application |
Drug Discovery & Development, Disease Modeling & Drug Simulation, Bioinformatics Research, and Others |
|
By End User |
Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Healthcare Organizations, and Others |
Report Highlights:
- Computational biology market size is accounted for USD 8.19 Billion in 2026.
- Target market size is estimated to be valuated at USD 26.63 Billion by 2036 and at a registered CAGR of 13%.
- Predicated on component, the software sector dominates the computational biology market share.
- With relevance to tools, databases dominate the computational biology market size.
- Dealing with the subject of deployment model, the cloud-based deployment approach dominates the computational biology market share.
- Drug discovery and development dominates the computational biology market share, by application.
- Pharmaceutical and biotechnology businesses dominate the computational biology market size, by end user.
- North America dominates the computational biology market share.
- Europe is the second-largest region in the computational biology market share.
Market Dynamics:
|
Growing Factor |
Challenge Factor |
Market Trend |
|
Expanding pharmaceutical R&D activities |
Complexity of biological data integration |
Availability of cloud-based computational tools
|
Key Highlights:
- In November 2024, NVIDIA announced that worldwide pharmaceutical and techbio industry leaders, academic pioneers, and AI researchers will use the open-source NVIDIA BioNeMo Framework to improve drug discovery and molecule design. Researchers demand specialized biomolecular models and databases that allow them to collect large-scale insights in order to build treatments faster. The open-source BioNeMo Framework provides a set of accelerated computing tools for exponentially scaling AI models for biomolecular research, ushering in a new era of supercomputing in biopharma.
Report Analysis:
Fundamentals of Computational Biology:
Computational biology is an interdisciplinary area that studies, models, and analyzes biological systems using computer science, mathematics, and statistics principles. It entails the investigation of genes, proteins, cells, and complete organisms utilizing computational tools and algorithms to manage huge amounts of biological data, simulate complex biochemical processes, and predict biological behavior.
Sequence analysis, structural modeling, systems biology, bioinformatics, and data integration are key principles that allow researchers to uncover biological pathways, promote drug development, advance precision medicine, and facilitate data-driven decision-making in the life sciences.
Browse ∼70 market data tables and ∼55 figures through ∼220 slides and in-depth TOC on “Computational Biology Market, Size, Share, By Component [Hardware (High-Performance Computing (HPC) Systems, Cloud Computing Infrastructure, and Others), Software (Simulation & Modeling Software, Sequence Analysis Software, and Others), and Services (Contract Research Services, Consulting & Implementation, and Others)], Tools (Databases, Algorithms, Simulation Tools, and Others), Deployment Mode (Cloud-based, On-premises, and Hybrid), Application (Drug Discovery & Development, Disease Modeling & Drug Simulation, Bioinformatics Research, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Healthcare Organizations, and Others), and By Region - Trends, Analysis, and Forecast till 2036”
Segmentation:
By Component:
- Hardware
- High-Performance Computing (HPC) Systems
- Cloud Computing Infrastructure
- Others
- Software
- Simulation & Modeling Software
- Sequence Analysis Software
- Others
- Services
- Contract Research Services
- Consulting & Implementation
- Others
By Tools:
- Databases
- Algorithms
- Simulation Tools
- Others
By Deployment Model:
- Cloud-based
- On-premises
- Hybrid
By Application:
- Drug Discovery & Development
- Disease Modeling & Drug Simulation
- Bioinformatics Research
- Others
By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Healthcare Organizations
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
For more insights into Computational Biology Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/computational-biology-market-6101
Competitive Landscape of Computational Biology Market:
The key players operating computational biology market Dassault Systèmes, Schrödinger, Inc., Certara, QIAGEN, Simulations Plus, Genedata AG, Insilico Medicine, Numerion Labs, SilexPro, Compugen, Ginkgo Bioworks, DEEP GENOMICS, Thermo Fisher Scientific Inc., Illumina, Inc., and Bio-Rad Laboratories, Inc.
|
Company Name |
Dassault Systèmes |
|
Headquarter |
Vélizy-Villacoublay, France |
|
CEO |
Pascal Daloz |
|
Employee Count |
25,000 Employees |
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Custmoized Your ReportWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request for Discount



Quick contact
